Agreement and Precision Study | Clinical Trial

Key information

Conditions

Eye Abnormalities Congenital Abnormalities Congenital, Hereditary, and Neonatal Diseases and Abnormalities Eye Diseases Normal Eyes

Age range

22 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Illinois College of Optometry

Chicago, Illinois, 60616, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Provide voluntary written consent
Age at least 22 years old
For glaucoma group only, visual field defect and optic nerve damage consistent with glaucoma
For cornea group only, cornea abnormality

Exclusion criteria

Ocular condition that may affect ability to perform cornea measurements
Have or is suspected to have ocular infection
Unable to tolerate eye testing

Treatment and study plan

Pachymeter

Device

Measure the thickness of the cornea

Other names: TRK-3 auto kerato-refracto tonometer

Primary outcomes

Cornea thickness

Time frame: 1 day

thickness of the cornea

Sponsors and collaborators

Lead sponsor

Topcon Corporation

Industry

Registry information

Official study title

TRK-3 Agreement and Precision of Pachymetry Function

Important dates

Study start: 2025
Primary completion: 2025
Study completion: 2025
First posted: Dec 13, 2024
Registry last updated: Feb 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed